International Journal of Heart Failure 2024;6(4):176-178
doi:10.36628/ijhf.2024.0018
The Impact of the Novel Sodium-Dependent Glucose Cotransporter 2 Inhibitor, Enavogliflozin, on Cardiac Reverse Remodeling in Heart Failure Patients With Type 2 Diabetes Mellitus: A Case Series
Taeil YANG 1 ; Youngwoo JANG ; Wook-Jin CHUNG
Affiliations
Country
Republic of Korea
Language
English
备案号: 11010502037788, 京ICP备10218182号-8)